Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces to control appetite and blood sugar. Clinical trials show participants using semaglutide lost an average of 15 pounds per month during the first three months, with results continuing through one year of treatment. PlexusDx compounds semaglutide injections at licensed 503A pharmacies and delivers them to all 50 states without insurance requirements.

How Semaglutide Injections Work for Weight Loss

Semaglutide works by binding to GLP-1 receptors located in brain regions that govern appetite, hunger signals, and food cravings. When you inject semaglutide once weekly, it travels through your bloodstream and activates these receptors, sending fullness signals to your brain even when you eat smaller portions. This dual action—reduced hunger plus delayed stomach emptying—makes it easier to stick to lower calorie intake without constant hunger or cravings that derail most traditional diets.

The medication also improves how your body processes glucose, which can help stabilize energy levels and reduce afternoon crashes that often trigger snacking. Many patients report feeling satisfied after eating half their previous portion size within the first two weeks of starting treatment. Unlike appetite suppressants that simply block hunger signals, semaglutide reshapes your appetite biology at the receptor level, creating lasting changes in how your body experiences food.

Expected Weight Loss Results and Timeline

Most patients begin noticing appetite suppression within 2–7 days of their first semaglutide injection, though weight loss acceleration takes 2–4 weeks as your dose is optimized. Clinical trials show an average loss of 15 pounds in the first month, with cumulative results reaching 15–22% of total body weight by month twelve. Individual results vary based on starting weight, metabolism, diet quality, exercise consistency, and genetic factors that influence how your body responds to GLP-1 signaling.

PlexusDx offers the Precision Peptide Genetic Test to identify your specific GLP-1 receptor variants and other peptide-pathway genes, helping predict your likely response timeline and optimal dosing strategy. Patients with stronger GLP1R gene variants (like rs6923761) often see results earlier and may require lower doses, while those with certain FTO variants may benefit from extended treatment duration. Your dose may need to go up as your body adjusts, but PlexusDx pricing remains flat—your monthly cost won't increase as you advance through treatment.

Semaglutide Injection Administration and Dosing

PlexusDx semaglutide comes in pre-filled syringes or vials that you inject once per week into fatty tissue under your skin—typically the abdomen, thigh, or upper arm. Patients rotate injection sites weekly to prevent lipohypertrophy (thickened fatty tissue), and most report the needle is thin and injections cause minimal discomfort. Your treatment plan starts at the lowest effective dose and increases gradually every 2–4 weeks, allowing your body to adapt and minimizing gastrointestinal side effects.

Compounded semaglutide from PlexusDx licensed 503A pharmacies is dosed flexibly based on your individual response, unlike pre-manufactured pens with fixed dose increments. This personalized approach means your provider can fine-tune your dose to maximize weight loss while keeping side effects manageable. Most patients reach their optimal maintenance dose within 12–16 weeks, then continue weekly injections to sustain results indefinitely.

Side Effects and Safety Considerations

The most common side effects of semaglutide injections are gastrointestinal—nausea, vomiting, diarrhea, and constipation—which typically peak during dose escalation and improve within days as your body acclimates. Eating smaller, protein-rich meals and staying hydrated minimizes nausea; most patients experience zero side effects by month two. Rare but serious risks include pancreatitis (severe abdominal pain), thyroid tumors in animal studies (not confirmed in humans), and gallbladder issues in people with history of gallstones.

Semaglutide is contraindicated in people with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, and requires caution in those with diabetic retinopathy or severe kidney disease. PlexusDx requires a medical assessment before starting treatment and ongoing provider oversight to monitor for adverse events. All compounded medications come with detailed safety information, and your PlexusDx provider can adjust or discontinue treatment immediately if concerning symptoms emerge.

Cost and Access: Semaglutide at PlexusDx

PlexusDx compounds semaglutide injections starting at $149 per month, with pricing remaining consistent regardless of your dose level or treatment duration. No insurance, membership fee, or prior authorization is required—PlexusDx serves all 50 states and accepts HSA and FSA funds for immediate tax-advantaged savings. Your first-month cost covers medication, shipment, and provider consultation to design your personalized protocol.

For patients wanting to explore genetic predictors of their GLP-1 response, the Precision Peptide Genetic Test is available for $99 after your first month of treatment. This test maps 14 peptide pathways, identifies variants in GLP1R, GIPR, FTO, MC4R, and 150+ other genetic insights that influence appetite control and weight loss potential. Combined semaglutide treatment plus genetic testing gives you data-driven clarity on why your body responds the way it does and how to optimize long-term results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results from semaglutide injections?

Appetite suppression typically begins within 2–7 days of your first injection, but measurable weight loss usually appears within 2–4 weeks as your dose is optimized. Most patients lose 15 pounds in the first month and 15–22% of body weight by one year. Results depend on your genetics, diet quality, exercise, and how well your GLP-1 receptors respond to the medication.

Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic or Wegovy?

PlexusDx semaglutide is compounded at licensed 503A pharmacies using the same active pharmaceutical ingredient as brand-name versions, delivering identical clinical efficacy when dosed appropriately. The key difference is personalized dosing flexibility and lower cost—your dose can be adjusted precisely to your needs without the fixed increments of pre-manufactured pens. Studies show compounded GLP-1 produces equivalent weight loss outcomes when administered by experienced providers.

Can I use HSA or FSA funds to pay for PlexusDx semaglutide?

Yes, PlexusDx semaglutide injections are HSA and FSA eligible, allowing you to save 20–40% of the cost through pre-tax deductions. At $149/month, semaglutide compounded at PlexusDx is also significantly more affordable than brand-name alternatives, and no insurance approval is required. Your compounded medication qualifies under IRS guidelines for tax-advantaged health spending accounts.

What happens if I experience nausea or other side effects from semaglutide?

Nausea is the most common side effect and typically resolves within days to a week as your body adapts; eating smaller, protein-rich meals and staying hydrated significantly reduces it. If side effects persist or worsen, your PlexusDx provider can slow your dose escalation schedule, adjust meal timing, or discontinue treatment. Serious side effects like severe abdominal pain require immediate medical attention and treatment interruption.

How does the Precision Peptide Genetic Test help with semaglutide treatment?

The test identifies your GLP1R and GIPR variants, which predict how strongly your brain's appetite centers will respond to semaglutide and how quickly you'll see results. Patients with favorable GLP1R variants often need lower doses and see faster weight loss, while others may benefit from longer treatment or combination therapy. For $99 after your first month, this genetic insight personalizes your dosing strategy and helps set realistic timelines for your weight loss goals.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves